Nestlé is evaluating a sale of underperforming vitamin and supplement brands.
Nestlé is reviewing strategic options for its underperforming vitamin, mineral and supplement segment, including potential divestment of brands such as Nature’s Bounty, Osteo Bi-Flex and Puritan’s Pride. CEO Laurent Freixe aims to sharpen focus on more profitable premium labels like Garden of Life.
Nestlé’s review mirrors a sector-wide trend: Unilever recently sold several consumer brands and plans to spin off its ice cream division. By trimming slower-growing units inherited from its previous leadership, the Swiss giant seeks to accelerate growth among higher-margin lines.
In H1 2025, group sales slipped 1.9%, largely due to adverse currency effects. Excluding forex, modest volume growth was achieved through price hikes on key brands such as Nespresso and KitKat. Nestlé reported a net profit of CHF 5.1 billion (≈ €5.4 billion), down 10% year-on-year, yet maintained its full-year outlook despite “increased headwinds.”
